Comparison of different prostate-specific antigen cutpoints for early detection of prostate cancer: Results of a large screening study
Authors:
- J. PointnerJPJ. Pointner
- W. HorningerWHW. Horninger
- O. EnnemoserOEO. Ennemoser
- H. StrasserHSH. Strasser
- H. KlockerHKH. Klocker
- G. BartschGBG. Bartsch
- 30 November 1995
- Vol. 46 (5) , 662-665
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The Use of Age-Specific Reference Ranges for Serum Prostate Specific Anitgen in Men 60 years Old or OlderJournal of Urology, 1995
- Selection of Optimal Prostate Specific Antigen Cutoffs for Early Detection of Prostate Cancer: Receiver Operating Characteristic CurvesJournal of Urology, 1994
- Prostate Specific Antigen Levels in Men Older than 50 Years without Clinical Evidence of Prostatic CarcinomaJournal of Urology, 1993
- Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference rangesJAMA, 1993
- Prevalence and Pathological Extent of Prostate Cancer in Men with Prostate Specific Antigen Levels of 2.9 to 4.0 NG./ML.Journal of Urology, 1993
- Prostate-specific antigen. Improving its ability to diagnose early prostate cancer1992
- Screening for Prostatic Carcinoma with Prostate Specific AntigenJournal of Urology, 1992
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991
- Prostate Cancer Detection in a Clinical Urological Practice by Ultrasonography, Digital Rectal Examination and Prostate Specific AntigenJournal of Urology, 1990
- Prediction of Prognosis for Prostatic Adenocarcinoma by Combined Histological Grading and Clinical StagingJournal of Urology, 1974